BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7884832)

  • 1. Influence of efonidipine hydrochloride, calcium antagonist on the epithelium of prostates in spontaneously hypertensive rats.
    Furukawa S; Yamamoto O; Tamura T; Masuda Y; Shudo C; Hayashi K; Hirata H
    J Toxicol Sci; 1994 Nov; 19(4):213-7. PubMed ID: 7884832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats.
    Fujiwara K; Kanno Y; Hayashi K; Takenaka T; Saruta T
    Clin Exp Hypertens; 1998 Apr; 20(3):295-312. PubMed ID: 9605384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal protective effect of efonidipine hydrochloride (NZ-105), a new calcium antagonist, in spontaneously hypertensive rats.
    Shudo C; Masuda Y; Sugita H; Furukawa S; Hayashi K; Hirata H; Tanaka S; Tomita K
    Gen Pharmacol; 1994 Dec; 25(8):1567-75. PubMed ID: 7721030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the antihypertensive drug efonidipine hydrochloride on albuminuria and renal histopathology in young spontaneously hypertensive rats with diabetes.
    Takeda M; Shou I; Tomino Y
    Gen Pharmacol; 1998 May; 30(5):749-52. PubMed ID: 9559329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term oral administration of NZ-105, a novel calcium antagonist, with or without propranolol in spontaneously hypertensive rats.
    Shudo C; Masuda Y; Sakai T; Tanaka S; Shigenobu K; Kasuya Y
    J Pharm Pharmacol; 1993 Jun; 45(6):525-9. PubMed ID: 8103100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of efonidipine hydrochloride on renal arteriolar diameters in spontaneously hypertensive rats.
    Nakamura M; Notoya M; Kohda Y; Yamashita J; Takashita Y; Gemba M
    Hypertens Res; 2002 Sep; 25(5):751-5. PubMed ID: 12452329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of efonidipine hydrochloride (NZ-105), a calcium antagonist, on renal function in conscious spontaneously hypertensive rats.
    Yotsumoto T; Masuda Y; Shudo C; Sugita H; Yamashita T; Tanaka S
    Gen Pharmacol; 1995 Mar; 26(2):333-7. PubMed ID: 7590083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonist inhibits glomerular cell apoptosis and injuries of L-NAME exacerbated nephrosclerosis in SHR.
    Watanabe S; Ono H; Ishimitsu T; Matsuoka H; Ono Y; Fujimori T
    Hypertens Res; 2000 Nov; 23(6):683-91. PubMed ID: 11131282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the antihypertensive drug nifedipine on albuminuria and renal histopathology in young spontaneously hypertensive rats with diabetes.
    Kaneko S; Takizawa H; Takeda M; Shou I; Tomino Y
    Gen Pharmacol; 1999 Nov; 33(5):363-7. PubMed ID: 10553876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of efonidipine, nicardipine and captopril on proteinuria in aged spontaneously hypertensive rats.
    Shudo C; Masuda Y; Sugita H; Tamura T; Furukawa S; Hayashi K; Hirata H; Shikada K; Tanaka S; Tomita K
    Arzneimittelforschung; 1996 Sep; 46(9):852-4. PubMed ID: 8876932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury.
    Kawabata M; Ogawa T; Han WH; Takabatake T
    Clin Exp Pharmacol Physiol; 1999 Sep; 26(9):674-9. PubMed ID: 10499155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute antihypertensive effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)-carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitrophen yl) octyl ester on conscious spontaneously hypertensive rats and renal hypertensive rats.
    Hojo M; Tanaka Y; Katayama O; Teramoto N
    Arzneimittelforschung; 1993 Aug; 43(8):847-51. PubMed ID: 8216440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
    Harada K; Nomura M; Nishikado A; Uehara K; Nakaya Y; Ito S
    Circ J; 2003 Feb; 67(2):139-45. PubMed ID: 12547996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of NZ-105, a new calcium antagonist, on renal function in anesthetized spontaneously hypertensive rats.
    Yokoyama T; Masuda Y; Sakai T; Tanaka S; Tomita K
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):851-6. PubMed ID: 1376803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal vascular responses in spontaneously hypertensive rats chronically treated with manidipine.
    Muratani H; Takishita S; Kawazoe N; Tozawa M; Fukiyama K
    Blood Press Suppl; 1992; 3():60-7. PubMed ID: 1343293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.
    Morimoto S; Jo F; Maki K; Iwasaka T
    Clin Exp Hypertens; 2009 Feb; 31(1):83-91. PubMed ID: 19172462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of calcium antagonist, manidipine hydrochloride, on renal hemodynamics and tubuloglomerular feedback in spontaneously hypertensive rats.
    Takabatake T; Ushiogi Y; Ise T; Kobayashi K
    Am Heart J; 1993 Feb; 125(2 Pt 2):578-81. PubMed ID: 8430603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term treatment with the calcium antagonist AE0047 on cerebrovascular autoregulation and hypertrophy in spontaneously hypertensive rats.
    Shinyama H; Nagai H; Kawamura T; Narita Y; Nakamura N; Kagitani Y
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):616-22. PubMed ID: 9388044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of efonidipine hydrochloride on myocardial oxygen balance in anesthetized dogs].
    Fujikura N; Yokoyama T; Masuda Y; Shikada K; Tanaka S
    Nihon Yakurigaku Zasshi; 1996 Aug; 108(2):39-48. PubMed ID: 8827722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of different dihydropyridine-type Ca2+ antagonists on left ventricle hypertrophy and coronary changes in spontaneously hypertensive rats.
    Tomassoni D; Sabbatini M; Amenta F
    J Cardiovasc Pharmacol; 2003 Apr; 41(4):544-52. PubMed ID: 12658055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.